Insider Trading Pulse — July 22, 2026

CEO Regan Kenneth P bought $1.46M in Limited Partnership Units at $25.50, a massive insider purchase that signals strong conviction in the company's value and future prospects. This is the most significant bullish signal in the digest.

CEO Liu Chang bought 9,287 ADS at $2.17 (~$20.1K), increasing his stake. This is a clear vote of confidence from the top executive in a small-cap stock, often a precursor to positive developments.

10% owner Control Empresarial de Capitales S.A. de C.V. sold $7.72M in shares at $64.35, a substantial reduction by a major shareholder. This is a strong bearish signal, suggesting a lack of confidence in the near-term outlook for the refining sector.

President & CEO Happel David sold $497K, and the Chief Legal Officer sold $81.8K, a coordinated sell-off by top management. This is a significant red flag, especially for a biotech where insider sentiment is critical.

Chairman & CEO ROGERS WILLIAM H JR sold 13,250 shares for $694K. A large sale by the top executive at a major regional bank is a notable bearish signal, potentially indicating concerns about the bank's outlook or sector headwinds.

COO Ye Gang sold $1.67M in shares under a 10b5-1 plan. While pre-planned, the sheer size of the sale ($1.67M) by a top operating executive is a bearish signal, suggesting a desire to lock in gains at current levels.

FRANKLIN RESOURCES INC sold $19M in shares. A massive sell-off by a major institutional holder is a significant bearish signal for the fund's near-term price performance.

Chairman & CEO RICHARDSON EDWARD J was awarded 20,000 shares and 20,000 options. While not a sale, this large equity grant aligns management with shareholders but also signals potential future dilution. [NEUTRAL/BULLISH]

President Weeks Brad Allan bought 60,000 shares at $0.05 (~$3K). A penny stock insider purchase, while small in dollar terms, shows insider confidence at a very low price point, often a speculative but potentially high-reward signal.

COO Kirol Charles Peter sold 3,198 shares at $6.49 under a 10b5-1 plan. A sale by a key executive at a struggling company is a bearish signal, reinforcing the negative sentiment around the stock.

President & CEO and Chief Legal Officer sold shares on the same day, a coordinated sell-off by top management. This is a high-risk flag for a clinical-stage biotech where insider confidence is paramount.

10% owner Control Empresarial de Capitales S.A. de C.V. sold $7.72M in a single day. This level of selling by a major holder is a strong signal of potential fundamental weakness or a negative outlook for the energy sector.

Chairman & CEO sold $694K in stock. A large, unscheduled sale by the top executive at a major financial institution is a significant red flag that warrants investigation into the bank's health and sector outlook.

FRANKLIN RESOURCES INC sold $19M, a massive reduction by a major institutional investor. This could signal a loss of confidence in the fund's strategy or the broader real estate income sector.

COO Ye Gang sold $1.67M under a 10b5-1 plan. While pre-planned, the size of the sale is a risk flag, as it represents a significant cash-out by a top operating executive, potentially indicating a peak in the stock's valuation.

COO sold shares at a depressed price of $6.49. Insider selling at a multi-year low is a bearish signal, suggesting even management lacks confidence in a turnaround.

The company awarded shares and options to the entire executive team and board. While a retention tool, this creates significant overhang and potential future selling pressure, diluting existing shareholders.

CFO & COO was awarded 1.3M shares, and the General Counsel was awarded 312,500 shares. These massive grants are highly dilutive and could signal that the company is using stock as a primary compensation tool, potentially masking cash flow issues.

President and CEO was awarded 50,000 shares, and the CFO was awarded 34,000 shares. While not a sale, the large awards create a future overhang and potential selling pressure once vested.

CEO Regan Kenneth P bought $1.46M in units at $25.50. This is a massive vote of confidence in the real estate sector. Investors should investigate the company's portfolio and growth prospects as a potential value play.

CEO Liu Chang bought shares at $2.17. This is a strong signal from an insider at a beaten-down small-cap. A potential catalyst could be a new product launch or earnings beat.

President Weeks Brad Allan bought 60,000 shares at $0.05. This is a speculative but potentially high-reward opportunity. The insider's purchase at a near-zero price point suggests a potential turnaround or upcoming catalyst.

VP Lin Shueh-Shyh bought 1,000 shares at ~$74. While a small trade, it is a rare insider buy at a major semiconductor company, potentially signaling a bottom in the stock or confidence in the company's long-term outlook.

Two directors bought shares at $12.18. Insider buying at a real estate fund could signal that the fund's assets are undervalued and that the NAV is likely to increase.

10% owner Chernett Jorey bought 18,000 shares at $5.27. This is a bullish signal from a major shareholder who is already heavily invested, suggesting confidence in the company's oncology pipeline.

Bacic William K bought 184 shares at $40.62. Insider buying in a closed-end fund can signal that the fund's discount to NAV is too wide and a correction is due.

Bacic William K also bought 308 shares at $11.48. Similar to the above, this is a signal that the fund's shares are undervalued relative to their income-generating potential.

The $7.72M sale by a 10% owner of PBF Energy is a major red flag for the refining sector. This suggests that major holders are taking profits or hedging against a downturn in energy prices or refining margins. Investors should be cautious on other energy names.

The coordinated sell-off by the CEO and CLO at Sagimet Biosciences is a bearish signal for the biotech sector. This pattern suggests that even company insiders are not confident in the near-term pipeline or stock price, a key risk for speculative biotech investments.

The CEO of Truist Financial sold $694K, a bearish signal, while other financial firms like Associated Banc-Corp and Progressive Corp issued routine equity awards. This divergence suggests that while some banks may face headwinds, others are in a normal compensation cycle.

The $1.46M CEO purchase at Sterling Real Estate Trust is a strong bullish signal for the real estate sector, contrasting with the institutional exit from Clarion Partners Real Estate Income Fund. This suggests a divergence between public REITs and private/interval funds.

Insider selling at Sea Ltd and Peloton is bearish, while insider buying at 17 Education & Technology Group and TSMC is bullish. This indicates a stock-specific, rather than sector-wide, trend in tech.

Multiple companies (Richardson Electronics, TON Strategy, Pixelworks) issued large equity grants to executives. While this aligns interests, the sheer volume of awards creates significant dilution and potential future selling pressure, a pattern that should be monitored closely.

Watch for any clinical trial updates or partnership announcements following the insider sell-off. The next earnings call will be critical to understand the CEO's rationale.

Monitor for further selling by the 10% owner and any guidance changes on the next earnings call. The refining margin environment will be a key factor.

Watch for any additional insider sales by the CEO or other top executives. The upcoming earnings call will be crucial for assessing the bank's net interest margin and loan loss provisions.

Monitor for any additional insider buying or company announcements that could justify the CEO's large purchase. The next quarterly report will be key.

Track the vesting schedules of the large equity awards. If the stock price appreciates, watch for a wave of insider selling as executives cash in their options.

Monitor the fund's discount to NAV and any further institutional selling. A widening discount could present a buying opportunity if the fundamentals are sound.

Watch for any positive news flow or earnings surprises that could validate the CEO's insider buying. The stock is a small-cap, so any positive catalyst could lead to significant upside.

Monitor the COO's remaining holdings and any further sales under the 10b5-1 plan. The company's next earnings report will be key to see if the operational performance justifies the insider selling.